£74.43

About as cheap as it gets — within 5% of the all-time low it hit 1 month ago.

£74 today · all-time low £74 (Sep 2026) · usually the usual

Springer Resistance to Ibritumomab in Lymphoma: 18 (Resistance to Targeted Anti-Cancer Therapeutics, 18)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 59 days · 59 data points (no recent data)

Historical
Generating forecast…
£76.42 £73.93 £74.48 £75.02 £75.56 £76.10 £76.65 26 July 2026 09 August 2026 24 August 2026 07 September 2026 22 September 2026
View at Amazon ↗

Price data last checked 32 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 59 days • 2 price levels

Days at Price
Current Price
15 days · current 44 days 0 11 22 33 44 £74 £76 Days at Price

Price Analysis

Most common price: £76 (44 days, 74.6%)

Price range: £74 - £76

Price levels: 2 different prices over 59 days

Description

This volume, in discussing resistance to ibritumomab, will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects, and medical physics that deal with radiation dosimetry, and will outline future prospects for overcoming resistance and enhancing efficacy of ibritumomab.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
07 May 2018
Listed Since
20 February 2018

Barcode

No barcode data available

Similar Products You Might Like

Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)
97% match

Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)

Springer

£60.64 18 Sep 2026
Resistance to Ibritumomab in Lymphoma: 18 (Resistance to Targeted Anti-Cancer Therapeutics, 18)
96% match

Resistance to Ibritumomab in Lymphoma: 18 (Resistance to Targeted Anti-Cancer Therapeutics, 18)

Springer

£73.77 24 Sep 2026
Lymphoma: Methods and Protocols - Volume 971 Research Guide
96% match

Lymphoma: Methods and Protocols - Volume 971 Research Guide

Humana

£101.40 02 Oct 2026
Aggressive Lymphomas (Hematologic Malignancies)
96% match

Aggressive Lymphomas (Hematologic Malignancies)

Springer

£89.28 24 Sep 2026
Non-Hodgkin Lymphoma: Pathology, Imaging, and Current Therapy: 165 (Cancer Treatment and Research, 165)
96% match

Non-Hodgkin Lymphoma: Pathology, Imaging, and Current Therapy: 165 (Cancer Treatment and Research, 165)

Springer

£65.61 22 Sep 2026
Radiotherapy for Hodgkin Lymphoma
96% match

Radiotherapy for Hodgkin Lymphoma

Springer

£62.16 25 Sep 2026
Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)
96% match

Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)

Springer

£122.35 24 Sep 2026
Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)
96% match

Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)

Springer

£179.99 30 Sep 2026
Innovative Leukemia and Lymphoma Therapy: 35 (Basic and Clinical Oncology)
96% match

Innovative Leukemia and Lymphoma Therapy: 35 (Basic and Clinical Oncology)

CRC Press

£163.39 01 Oct 2026
Lymphoma and Leukemia of the Nervous System
95% match

Lymphoma and Leukemia of the Nervous System

Springer

£107.85 19 Sep 2026
Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)
95% match

Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)

Springer

£88.34 24 Sep 2026
Lymphoma: Methods and Protocols: 1956 (Methods in Molecular Biology, 1956)
95% match

Lymphoma: Methods and Protocols: 1956 (Methods in Molecular Biology, 1956)

Humana

£122.54 18 Sep 2026
T-Cell Lymphomas (Contemporary Hematology)
95% match

T-Cell Lymphomas (Contemporary Hematology)

Humana

£80.67 11 Sep 2026
Lymphoma: Diagnosis and Treatment: 43 (Current Clinical Oncology, 43)
95% match

Lymphoma: Diagnosis and Treatment: 43 (Current Clinical Oncology, 43)

Humana

£141.67 18 Sep 2026
PET/CT in Lymphomas: A Case-Based Atlas
95% match

PET/CT in Lymphomas: A Case-Based Atlas

Springer

£85.16 24 Sep 2026
Novel Therapeutics for Rare Lymphomas
95% match

Novel Therapeutics for Rare Lymphomas

Springer

£61.84 18 Sep 2026
Cancer Therapy: Monoclonal Antibodies, Lymphokines New Developments in Surgical Oncology and Chemo- and Hormonal Therapy
95% match

Cancer Therapy: Monoclonal Antibodies, Lymphokines New Developments in Surgical Oncology and Chemo- and Hormonal Therapy

Springer

£78.85 13 Sep 2026
Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)
95% match

Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)

Springer

£87.93 01 Oct 2026
Humana Gene and Cellular Immunotherapy for Cancer Book
95% match

Humana Gene and Cellular Immunotherapy for Cancer Book

Humana

£106.78 04 Sep 2026
Blut und Blutkrankheiten: Fünfte Völlig Neu Bearbeitete und Erweiterte Auflage: 2 / 7 (Handbuch der inneren Medizin, 2 / 7)
95% match

Blut und Blutkrankheiten: Fünfte Völlig Neu Bearbeitete und Erweiterte Auflage: 2 / 7 (Handbuch der inneren Medizin, 2 / 7)

Springer

£58.09 03 Oct 2026
Mantle Cell Lymphoma, An Issue of Hematology/Oncology Clinics of North America: Volume 34-5 (The Clinics: Internal Medicine, Volume 34-5)
95% match

Mantle Cell Lymphoma, An Issue of Hematology/Oncology Clinics of North America: Volume 34-5 (The Clinics: Internal Medicine, Volume 34-5)

Elsevier

£76.79 01 Oct 2026